Indeed, a recent study showed that LOX1+ identifies a specific PMN-MDSC subpopulation that is increased in GB patients’ blood and tumor tissue and is characterized by a high expression of ARG1 and iNOS and strong immunosuppressive ability to inhibit CD3+ T cells [52]. The gene discussed is OLR1; the disease is neoplasm.